Evaluation of Endobronchial Ultrasound (EBUS) for Staging Lung Cancer (EBUS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01799980|
Recruitment Status : Completed
First Posted : February 27, 2013
Last Update Posted : March 21, 2019
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||37 participants|
|Official Title:||Evaluation of Endobronchial Ultrasound (EBUS) for Staging Lung Cancer|
|Study Start Date :||June 2012|
|Actual Primary Completion Date :||December 2018|
|Actual Study Completion Date :||December 2018|
This group will undergo cervical mediastinoscopy before surgery to stage their lung cancer (procedure decided by the surgeon).
This group will undergo endobronchial ultrasound before surgery to stage their lung cancer (procedure decided by the surgeon).
- Lung cancer staging [ Time Frame: Pre-op and post-op ]Lung cancer staging (assessed by either cervical mediastinoscopy or EBUS) will be compared both pre-op and post-op.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01799980
|Ottawa Hospital Research Institute|
|Ottawa, Ontario, Canada, K1H8L6|
|Principal Investigator:||Donna E Maziak, MD, MSc||Ottawa Hospital Research Institute|